Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]:
SEC Accession No. 0001035704-03-000189
Filing Date
2003-03-31
Accepted
2003-03-31 15:31:15
Documents
4
Period of Report
2002-12-31

Document Format Files

Seq Description Document Type Size
1 FORM 10-K d04322e10vk.htm 10-K 803471
3 EX-23.1 CONSENT OF ERNST & YOUNG LLP d04322exv23w1.htm EX-23.1 849
4 EX-23.2 INFORMATION RE: CONSENT OF ARTHUR ANDERSEN d04322exv23w2.htm EX-23.2 2833
5 EX-99.1 CERTIFICATION PURSUANT TO 18 U.S.C. 1350 d04322exv99w1.htm EX-99.1 2434
  Complete submission text file 0001035704-03-000189.txt   811511
Mailing Address 301 CONGRESS AVE SUITE 1850 AUSTIN TX 78701
Business Address 301 CONGRESS AVE SUITE 1850 AUSTIN TX 78701 5127089310
INTROGEN THERAPEUTICS INC (Filer) CIK: 0001018710 (see all company filings)

EIN.: 742704230 | Fiscal Year End: 1231
Type: 10-K | Act: 34 | File No.: 000-21291 | Film No.: 03630195
SIC: 2834 Pharmaceutical Preparations